[High risk cytogenetic abnormalities in patients with multiple myeloma]

Rev Med Chil. 2019;147(1):61-64. doi: 10.4067/S0034-98872019000100061.
[Article in Spanish]

Abstract

Background: Cytogenetic abnormalities observed in the bone marrow of patients with multiple myeloma (MM) are an important prognostic factor for risk stratification.

Aim: To investigate karyotype characteristics and frequency of the high-risk cytogenetic abnormalities t(4;14), t(14;16) and del(17p) in Chilean patients with MM.

Material and methods: We studied 30 patients with MM by conventional cytogenetics (CC) and fluorescent in situ hybridization of plasma cells selected using cytoplasmic immunoglobulin staining (cIg-FISH).

Results: Overall, the two techniques in combination allowed us to identify clonal genetic abnormalities in 47% of patients. The t(4;14) abnormality was observed in 19% of patients, del(17p) was observed in 10% of patients, and t(14;16) was not detected.

Conclusions: Our results showed frequencies of high-risk abnormalities similar to those reported abroad. Cytogenetic studies should be performed routinely for all MM patients at the moment of diagnosis.

MeSH terms

  • Adult
  • Aged
  • Chile
  • Chromosome Aberrations*
  • Cytogenetic Analysis / methods
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence / methods
  • Karyotype
  • Male
  • Middle Aged
  • Multiple Myeloma / genetics*
  • Reference Values
  • Risk Assessment / methods
  • Risk Factors